Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Trump vs. Harris: How Could the US Election Affect the Gold Price?

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

A Guide to Investing in Physical Gold (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

How Will the US Election Affect the Crypto Industry?

7 Biggest Lithium-mining Companies in 2024

Should You Invest in Silver Bullion? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Trending Press Releases

MOU Signed with Volkov Geology

Argentina Lithium Announces Receipt of Drill Permit for the Paso de Sico Property at its Rincon West Lithium Project

New Exceptionally High-Grade Gold Intersections from Infill Drilling at Crown Prince

Alta Mesa Passes Key Milestone in Uranium Production Ramp-Up

Outstanding Copper-Nickel Discovery

Grid Battery Metals Update - Drilling Completed on its Clayton Valley Lithium Project

More Press Releases
Trending Companies

Controlled Thermal Resources

Falco Resources

FPC:CC

Red Metal Resources

RMES:CC

Brunswick Exploration

BRW:TCM
More Companies
Trending Reports

2024 Lithium Market Outlook

2024 Copper Outlook Report

2024 Gold Outlook Report

Rare Earths Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Moleculin Biotech Inc.

NASDAQ:MBRX
Press Releases

Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia

Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Interactive Chart

×